In patients with HL, pre-treatment levels of VEGF and HGF were elevated but significantly reduced after therapy, and both pre- and post-treatment VEGF levels were found to be predictive of survival [25]. This evidence concerns the gene VEGFA and Hodgkins lymphoma.